Neurobehavioral Disorders
More Neurobehavioral Disorders News

Neurobehavioral Disorders News

Features

 More Neurobehavioral Disorders features
Aducanumab, Lecanemab for Early AD: The Clinical Trials That Led to FDA Approval
 By Tori Rodriguez, MA, LPC, AHC

These are the clinical trials that led to the FDA’s approval of aducanumab and lecanemab for early AD, plus, the concerns that loom.
Neurotechnologies for Alzheimer Disease Are Emerging: Here’s What We Know So Far
 By Tori Rodriguez, MA, LPC, AHC
A Look at the Effect of Sleep Patterns on Cardiovascular Health
 By Tori Rodriguez, MA, LPC, AHC
Insomnia and Sleep Apnea Is a Challenging Co-Occurrence: Here’s What We Know
 By Nicola Davies, PhD

Features

Aducanumab, Lecanemab for Early AD: The Clinical Trials That Led to FDA Approval
 By Tori Rodriguez, MA, LPC, AHC
Neurotechnologies for Alzheimer Disease Are Emerging: Here’s What We Know So Far
 By Tori Rodriguez, MA, LPC, AHC
A Look at the Effect of Sleep Patterns on Cardiovascular Health
 By Tori Rodriguez, MA, LPC, AHC
Insomnia and Sleep Apnea Is a Challenging Co-Occurrence: Here’s What We Know
 By Nicola Davies, PhD

Conference Coverage

MORE MEETINGS

Featured Conference

Consortium of Multiple Sclerosis Centers

Clinical Tools

Powered by

Powered by   
Drug Look-up
Select a category
Drug Comparison Charts
Select a category
Calculators
Select a category
MORE CLINICAL TOOLS

CME/CE

MORE COURSES